Skip to content
Subscriber Only

Glaxo’s Vaccines Chairman Moncef Slaoui to Retire Next Year

  • Slaoui to leave board in March, remain as adviser until July
  • Debruyne to continue to run Glaxo’s vaccine business
Updated on

GlaxoSmithKline Plc’s vaccines division chief, Moncef Slaoui, will retire next year after a nearly 30-year career at the U.K.’s biggest drugmaker.

Slaoui will remain a member of the board until March 31, and leave the company on June 30, 2017, the London-based company said in a statement on Tuesday. Slaoui joined Glaxo in 1988 and became a director in 2006.